Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.

Kuželová K, Brodská B, Schetelig J, Röllig C, Ráčil Z, Walz JS, Helbig G, Fuchs O, Vraná M, Pecherková P, Šálek C, Mayer J.

PLoS One. 2018 Dec 17;13(12):e0204290. doi: 10.1371/journal.pone.0204290. eCollection 2018.

2.

Detection and identification of fungi in bronchoalveolar lavage fluid from immunocompromised patients using panfungal PCR.

Ricna D, Lengerova M, Bezdicek M, Kocmanova I, Drgona L, Weinbergerova B, Mayer J, Racil Z.

Folia Microbiol (Praha). 2018 Dec 8. doi: 10.1007/s12223-018-00669-w. [Epub ahead of print]

PMID:
30535753
3.

JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation.

Czech J, Cordua S, Weinbergerova B, Baumeister J, Crepcia A, Han L, Maié T, Costa IG, Denecke B, Maurer A, Schubert C, Feldberg K, Gezer D, Brümmendorf TH, Müller-Newen G, Mayer J, Racil Z, Kubesova B, Knudsen T, Sørensen AL, Holmström M, Kjær L, Skov V, Larsen TS, Hasselbalch HC, Chatain N, Koschmieder S.

Leukemia. 2018 Nov 23. doi: 10.1038/s41375-018-0295-6. [Epub ahead of print]

PMID:
30470838
4.

The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients.

Belohlavkova P, Vrbacky F, Voglova J, Racil Z, Zackova D, Hrochova K, Malakova J, Mayer J, Zak P.

Arch Med Sci. 2018 Oct;14(6):1416-1423. doi: 10.5114/aoms.2018.73538. Epub 2018 Feb 15.

5.

European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.

Maertens JA, Girmenia C, Brüggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN) .

J Antimicrob Chemother. 2018 Dec 1;73(12):3221-3230. doi: 10.1093/jac/dky286.

PMID:
30085172
6.

Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.

Racil Z, Koritakova E, Sacha T, Klamova H, Belohlavkova P, Faber E, Rea D, Malaskova L, Prochazkova J, Zackova D, Voglova J, Wącław J, Cetkovsky P, Zak P, Mayer J.

Am J Hematol. 2018 Oct;93(10):E342-E345. doi: 10.1002/ajh.25232. Epub 2018 Aug 31. No abstract available.

PMID:
30054949
7.

The influence of mutational status and biological characteristics of acute myeloid leukemia on xenotransplantation outcomes in NOD SCID gamma mice.

Culen M, Kosarova Z, Jeziskova I, Folta A, Chovancova J, Loja T, Tom N, Bystry V, Janeckova V, Dvorakova D, Mayer J, Racil Z.

J Cancer Res Clin Oncol. 2018 Jul;144(7):1239-1251. doi: 10.1007/s00432-018-2652-2. Epub 2018 May 2.

PMID:
29721667
8.

Chromothripsis in acute myeloid leukemia: biological features and impact on survival.

Fontana MC, Marconi G, Feenstra JDM, Fonzi E, Papayannidis C, Ghelli Luserna di Rorá A, Padella A, Solli V, Franchini E, Ottaviani E, Ferrari A, Baldazzi C, Testoni N, Iacobucci I, Soverini S, Haferlach T, Guadagnuolo V, Semerad L, Doubek M, Steurer M, Racil Z, Paolini S, Manfrini M, Cavo M, Simonetti G, Kralovics R, Martinelli G.

Leukemia. 2018 Jul;32(7):1609-1620. doi: 10.1038/s41375-018-0035-y. Epub 2018 Feb 23.

9.

Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals.

Stallmach A, Anttila VJ, Hell M, Gwynn S, Merino-Amador P, Petrosillo N, Ráčil Z, Warren T, Wenisch C, Wilcox M.

Z Gastroenterol. 2018 Feb 9. doi: 10.1055/s-0044-100045. [Epub ahead of print]

PMID:
29426057
10.

Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission.

Vydra J, Šálek C, Schwarz J, Žák P, Novák J, Petečuková V, Pecherková P, Mayer J, Cetkovský P, Ráčil Z.

Clin Lymphoma Myeloma Leuk. 2018 Feb;18(2):106-113. doi: 10.1016/j.clml.2017.11.011. Epub 2017 Dec 7.

PMID:
29289481
11.

Chromothripsis in acute myeloid leukemia: Biological features and impact on survival.

Fontana MC, Marconi G, Feenstra JDM, Fonzi E, Papayannidis C, di Rorá AGL, Padella A, Solli V, Franchini E, Ottaviani E, Ferrari A, Baldazzi C, Testoni N, Iacobucci I, Soverini S, Haferlach T, Guadagnuolo V, Semerad L, Doubek M, Steurer M, Racil Z, Paolini S, Manfrini M, Cavo M, Simonetti G, Kralovics R, Martinelli G.

Leukemia. 2017 Dec 18. doi: 10.1038/leu.2017.351. [Epub ahead of print]

12.

Investigation of next-generation sequencing data of Klebsiella pneumoniae using web-based tools.

Brhelova E, Antonova M, Pardy F, Kocmanova I, Mayer J, Racil Z, Lengerova M.

J Med Microbiol. 2017 Nov;66(11):1673-1683. doi: 10.1099/jmm.0.000624. Epub 2017 Oct 25.

PMID:
29068275
13.

FungiScope -Global Emerging Fungal Infection Registry.

Seidel D, Durán Graeff LA, Vehreschild MJGT, Wisplinghoff H, Ziegler M, Vehreschild JJ, Liss B, Hamprecht A, Köhler P, Racil Z, Klimko N, Sheppard DC, Herbrecht R, Chowdhary A, Cornely OA, FungiScope Group.

Mycoses. 2017 Aug;60(8):508-516. doi: 10.1111/myc.12631.

PMID:
28730644
14.

[New Drugs in the Treatment of Acute Myeloid Leukemia in the Elderly].

Šustková Z, Čulen M, Semerád L, Ježíšková I, Dvořáková D, Ráčil Z, Mayer J.

Klin Onkol. Summer 2017;30(3):190-196. doi: 10.14735/amko2017190. Review. Czech.

PMID:
28612615
15.

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

Kayser S, Krzykalla J, Elliott MA, Norsworthy K, Gonzales P, Hills RK, Baer MR, Ráčil Z, Mayer J, Novak J, Žák P, Szotkowski T, Grimwade D, Russell NH, Walter RB, Estey EH, Westermann J, Görner M, Benner A, Krämer A, Smith BD, Burnett AK, Thiede C, Röllig C, Ho AD, Ehninger G, Schlenk RF, Tallman MS, Levis MJ, Platzbecker U.

Leukemia. 2017 Nov;31(11):2347-2354. doi: 10.1038/leu.2017.92. Epub 2017 Mar 21.

16.

Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry.

Durán Graeff L, Seidel D, Vehreschild MJ, Hamprecht A, Kindo A, Racil Z, Demeter J, De Hoog S, Aurbach U, Ziegler M, Wisplinghoff H, Cornely OA; FungiScope Group.

Mycoses. 2017 Apr;60(4):273-279. doi: 10.1111/myc.12595. Epub 2017 Feb 2.

PMID:
28150341
17.

[Molecular Genetic Testing for Acute Myeloid Leukemia].

Janečková V, Semerád L, Ježíšková I, Dvořáková D, Čulen M, Šustková Z, Mayer J, Ráčil Z.

Klin Onkol. Winter 2016;29(6):411-418. Review. Czech.

PMID:
27951719
18.

Serological Approaches.

Weinbergerova B, Kocmanova I, Racil Z, Mayer J.

Methods Mol Biol. 2017;1508:209-221.

PMID:
27837506
19.

Novel complex mutation in NPM1 gene in patient with acute myeloid leukemia.

Jeziskova I, Semerad L, Dvorakova D, Janeckova V, Culen M, Kunetkova T, Mayer J, Racil Z.

Leuk Lymphoma. 2017 Mar;58(3):746-748. doi: 10.1080/10428194.2016.1213832. Epub 2016 Aug 3. No abstract available.

PMID:
27484360
20.

Validation of Minim typing for fast and accurate discrimination of extended-spectrum, beta-lactamase-producing Klebsiella pneumoniae isolates in tertiary care hospital.

Brhelova E, Kocmanova I, Racil Z, Hanslianova M, Antonova M, Mayer J, Lengerova M.

Diagn Microbiol Infect Dis. 2016 Sep;86(1):44-9. doi: 10.1016/j.diagmicrobio.2016.03.010. Epub 2016 Mar 8.

PMID:
27394639
21.

Utility of voriconazole therapeutic drug monitoring: a meta-analysis.

Luong ML, Al-Dabbagh M, Groll AH, Racil Z, Nannya Y, Mitsani D, Husain S.

J Antimicrob Chemother. 2016 Jul;71(7):1786-99. doi: 10.1093/jac/dkw099. Epub 2016 May 10.

PMID:
27165788
22.

Rapid detection of fungal pathogens in bronchoalveolar lavage samples using panfungal PCR combined with high resolution melting analysis.

Bezdicek M, Lengerova M, Ricna D, Weinbergerova B, Kocmanova I, Volfova P, Drgona L, Poczova M, Mayer J, Racil Z.

Med Mycol. 2016 Oct 1;54(7):714-24. doi: 10.1093/mmy/myw032. Epub 2016 May 9.

PMID:
27161789
23.

Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.

Culen M, Borsky M, Nemethova V, Razga F, Smejkal J, Jurcek T, Dvorakova D, Zackova D, Weinbergerova B, Semerad L, Sadovnik I, Eisenwort G, Herrmann H, Valent P, Mayer J, Racil Z.

Oncotarget. 2016 May 31;7(22):33016-24. doi: 10.18632/oncotarget.9108.

24.

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR 3rd, Alangaden GJ, Brown JM, Fredricks DN, Heinz WJ, Herbrecht R, Klimko N, Klyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, Vehreschild JJ, Young JH, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher RM, Zeiher B, Vehreschild MJGT; VITAL and FungiScope Mucormycosis Investigators.

Lancet Infect Dis. 2016 Jul;16(7):828-837. doi: 10.1016/S1473-3099(16)00071-2. Epub 2016 Mar 9.

PMID:
26969258
25.

Disseminated fusariosis by Fusarium proliferatum in a patient with aplastic anaemia receiving primary posaconazole prophylaxis - case report and review of the literature.

Ricna D, Lengerova M, Palackova M, Hadrabova M, Kocmanova I, Weinbergerova B, Pavlovsky Z, Volfova P, Bouchnerova J, Mayer J, Racil Z.

Mycoses. 2016 Jan;59(1):48-55. doi: 10.1111/myc.12421. Epub 2015 Nov 2.

PMID:
26661324
26.

Limited efficacy of HLA-haploidentical peripheral blood stem cell infusion in treatment of elderly patients with acute myelogenous leukaemia.

Sustkova Z, Jeziskova I, Dvorakova D, Horky O, Semerad L, Weinbergerova B, Culen M, Mayer J, Racil Z.

Hematol Oncol. 2017 Jun;35(2):244-245. doi: 10.1002/hon.2254. Epub 2015 Aug 27. No abstract available.

PMID:
26310695
27.

Distribution of mutations in DNMT3A gene and the suitability of mutations in R882 codon for MRD monitoring in patients with AML.

Jeziskova I, Musilova M, Culen M, Foltankova V, Dvorakova D, Mayer J, Racil Z.

Int J Hematol. 2015 Nov;102(5):553-7. doi: 10.1007/s12185-015-1856-3. Epub 2015 Aug 20.

PMID:
26290145
28.

DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia.

Valent P, Sadovnik I, Ráčil Z, Herrmann H, Blatt K, Cerny-Reiterer S, Eisenwort G, Lion T, Holyoake T, Mayer J.

Eur J Clin Invest. 2014 Dec;44(12):1239-45. doi: 10.1111/eci.12368. Review.

PMID:
25371066
29.

Detecting human cytomegalovirus drug resistant mutations and monitoring the emergence of resistant strains using real-time PCR.

Volfova P, Lengerova M, Lochmanova J, Dvorakova D, Ricna D, Palackova M, Weinbergerova B, Mayer J, Racil Z.

J Clin Virol. 2014 Oct;61(2):270-4. doi: 10.1016/j.jcv.2014.07.008. Epub 2014 Jul 22.

PMID:
25130511
30.

BCR-ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next-generation sequencing.

Musilova M, Razga F, Jurcek T, Jeziskova I, Borsky M, Nemethova V, Zackova D, Culen M, Dvorakova D, Mayer J, Racil Z.

Am J Hematol. 2014 Oct;89(10):1016-7. doi: 10.1002/ajh.23794. Epub 2014 Jul 22. No abstract available.

31.

Rapid detection and identification of mucormycetes in bronchoalveolar lavage samples from immunocompromised patients with pulmonary infiltrates by use of high-resolution melt analysis.

Lengerova M, Racil Z, Hrncirova K, Kocmanova I, Volfova P, Ricna D, Bejdak P, Moulis M, Pavlovsky Z, Weinbergerova B, Toskova M, Mayer J.

J Clin Microbiol. 2014 Aug;52(8):2824-8. doi: 10.1128/JCM.00637-14. Epub 2014 May 21.

32.

Prospective analysis of low-level BCR-ABL1 T315I mutation in CD34 + cells of patients with de novo chronic myeloid leukemia.

Jurcek T, Razga F, Mazancova P, Musilova M, Dvorakova D, Borsky M, Zackova D, Dobesova B, Semerad L, Mayer J, Racil Z.

Leuk Lymphoma. 2014 Aug;55(8):1915-7. doi: 10.3109/10428194.2013.842988. Epub 2014 Feb 6. No abstract available.

PMID:
24304421
33.

Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2.

Klampfl T, Milosevic JD, Puda A, Schönegger A, Bagienski K, Berg T, Harutyunyan AS, Gisslinger B, Rumi E, Malcovati L, Pietra D, Elena C, Della Porta MG, Pieri L, Guglielmelli P, Bock C, Doubek M, Dvorakova D, Suvajdzic N, Tomin D, Tosic N, Racil Z, Steurer M, Pavlovic S, Vannucchi AM, Cazzola M, Gisslinger H, Kralovics R.

PLoS One. 2013 Oct 16;8(10):e77819. doi: 10.1371/journal.pone.0077819. eCollection 2013.

34.

No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia.

Racil Z, Razga F, Klamova H, Voglova J, Belohlavkova P, Malaskova L, Potesil D, Muzik J, Zackova D, Polakova KM, Zdrahal Z, Malakova J, Suttnar J, Dyr J, Mayer J.

Hematol Oncol. 2014 Jun;32(2):87-93. doi: 10.1002/hon.2091. Epub 2013 Aug 20. Erratum in: Hematol Oncol. 2014 Sep;32(3):168.

PMID:
23963760
35.

Current survival measures reliably reflect modern sequential treatment in CML: correlation with prognostic stratifications.

Pavlik T, Janousova E, Mayer J, Indrak K, Jarosova M, Klamova H, Zackova D, Voglova J, Faber E, Karas M, Machova Polakova K, Racil Z, Demeckova E, Demitrovicova L, Tothova E, Chudej J, Markuljak I, Cmunt E, Kozak T, Muzik J, Dusek L.

Am J Hematol. 2013 Sep;88(9):790-7. doi: 10.1002/ajh.23508. Epub 2013 Jul 23.

36.

Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.

Krejci M, Doubek M, Dusek J, Brychtova Y, Racil Z, Navratil M, Tomiska M, Horky O, Pospisilova S, Mayer J.

Ann Hematol. 2013 Oct;92(10):1397-403. doi: 10.1007/s00277-013-1790-5. Epub 2013 Jun 1.

PMID:
23728608
37.

Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.

Pagano L, Cornely OA, Busca A, Caira M, Cesaro S, Gasbarrino C, Girmenia C, Heinz WJ, Herbrecht R, Lass-Flörl C, Nosari A, Potenza L, Racil Z, Rickerts V, Sheppard DC, Simon A, Ullmann AJ, Valentini CG, Vehreschild JJ, Candoni A, Vehreschild MJ.

Haematologica. 2013 Oct;98(10):e127-30. doi: 10.3324/haematol.2012.083063. Epub 2013 May 28. No abstract available.

38.

Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia.

Racil Z, Razga F, Drapalova J, Buresova L, Zackova D, Palackova M, Semerad L, Malaskova L, Haluzik M, Mayer J.

Haematologica. 2013 Oct;98(10):e124-6. doi: 10.3324/haematol.2013.086355. Epub 2013 May 28. No abstract available.

39.

Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels.

Klamová H, Poláková KM, Mužík J, Ráčil Z, Záčková D, Steinerová K, Karas M, Faber E, Demečková E, Michalovičová-Sninská Z, Voglová J, Demitrovičová L, Mikušková E, Tóthová E, Chudej J, Markuljak I, Cmunt E, Moravcová J, Dvořáková D, Michalová K, Jarošová M, Sťastná MM, Cetkovský P, Dušek L, Koza V, Trněný M, Indrák K.

Cancer Med. 2013 Apr;2(2):216-25. doi: 10.1002/cam4.59. Epub 2013 Feb 21.

40.

Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials.

Zackova D, Klamova H, Muzik J, Cmunt E, Racil Z, Machova Polakova K, Dvorakova D, Jurcek T, Razga F, Cetkovsky P, Dusek L, Mayer J.

Leuk Lymphoma. 2013 Oct;54(10):2310-3. doi: 10.3109/10428194.2013.772173. Epub 2013 Feb 28. No abstract available.

PMID:
23373966
41.

Invasive mould disease involving the gastrointestinal tract caused by Neosartorya pseudofischeri in a haematological patient.

Toskova M, Palousova D, Kocmanova I, Pavlovsky Z, Timilsina S, Lengerova M, Mayer J, Racil Z.

Mycoses. 2013 May;56(3):385-8. doi: 10.1111/myc.12038. Epub 2013 Jan 29. No abstract available.

PMID:
23356572
42.

The BCR-ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy.

Malcikova J, Razga F, Jurcek T, Dvorakova D, Zackova D, Toskova M, Sebejova L, Smardova J, Oltova A, Vankova G, Jurackova L, Trbusek M, Pospisilova S, Mayer J, Racil Z.

Leuk Lymphoma. 2013 Sep;54(9):2083-7. doi: 10.3109/10428194.2012.762649. Epub 2013 Feb 1. No abstract available.

PMID:
23289360
43.
44.

[Detection and identification of filamentous fungi causing mycoses using molecular genetic methods].

Bejdák P, Lengerová M, Paloušová D, Volfová P, Kocmanová I, Mayer J, Ráčil Z.

Klin Mikrobiol Infekc Lek. 2012 Aug;18(4):109-14. Review. Czech.

PMID:
23172022
45.

[Invasive fungal infections in immunocompromised patients with focus on aspergillosis and its causative agents].

Paloušová D, Lengerová M, Volfová P, Bejdák P, Kocmanová I, Mayer J, Ráčil Z.

Klin Mikrobiol Infekc Lek. 2012 Aug;18(4):96-101. Review. Czech.

PMID:
23172020
46.

Micafungin as empirical antifungal therapy in hematological patients: a retrospective, multicenter study in the Czech and Slovak Republics.

Racil Z, Toskova M, Kocmanova I, Buresova L, Kouba M, Drgona L, Masarova L, Guman T, Tothova E, Gabzdilova J, Forsterova K, Haber J, Ziakova B, Bojtarova E, Rolencova M, Timilsina S, Cetkovsky P, Mayer J.

Leuk Lymphoma. 2013 May;54(5):1042-7. doi: 10.3109/10428194.2012.729057. Epub 2012 Nov 15.

PMID:
23088794
47.

Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.

Racil Z, Weinbergerova B, Kocmanova I, Muzik J, Kouba M, Drgona L, Masarova L, Guman T, Tothova E, Forsterova K, Haber J, Ziakova B, Bojtarova E, Vydra J, Mudry P, Foralova R, Sejnova D, Mallatova N, Kandrnal V, Cetkovsky P, Mayer J.

Int J Infect Dis. 2013 Feb;17(2):e101-9. doi: 10.1016/j.ijid.2012.09.004. Epub 2012 Oct 22.

48.

Clonal heterogeneity in patients with cytogenetically normal acute myeloid leukemia with NPM1 mutations.

Dvorakova D, Racil Z, Borsky M, Robesova B, Jeziskova I, Razga F, Lengerova M, Mayer J.

Leuk Lymphoma. 2013 May;54(5):1056-60. doi: 10.3109/10428194.2012.734618. Epub 2012 Oct 16.

PMID:
23020761
49.

Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene.

Jeziskova I, Razga F, Toskova M, Dvorakova D, Timilsina S, Mayer J, Racil Z.

Leuk Lymphoma. 2013 Apr;54(4):867-70. doi: 10.3109/10428194.2012.727414. Epub 2012 Sep 28. No abstract available.

PMID:
22950897
50.

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach.

Cornelissen JJ, Gratwohl A, Schlenk RF, Sierra J, Bornhäuser M, Juliusson G, Råcil Z, Rowe JM, Russell N, Mohty M, Löwenberg B, Socié G, Niederwieser D, Ossenkoppele GJ.

Nat Rev Clin Oncol. 2012 Oct;9(10):579-90. doi: 10.1038/nrclinonc.2012.150. Epub 2012 Sep 4. Review.

PMID:
22949046

Supplemental Content

Support Center